BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22245195)

  • 1. Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapy.
    Brown S; Vicini F; Vanapalli JR; Whitaker TJ; Pope DK; Lyden M; Bruggeman L; Haile KL; McLaughlin MP
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):801-5. PubMed ID: 22245195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
    Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
    Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
    Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
    Park Y; Kim HJ; Chang AR
    Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
    Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.
    Podder T; Biswas T; Yao M; Zhang Y; Kim E; Ellis RJ; Lo SS; Machtay M
    Future Oncol; 2014 Dec; 10(15):2311-7. PubMed ID: 25525841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy.
    Berger D; Kauer-Dorner D; Seitz W; Pötter R; Kirisits C
    Brachytherapy; 2008; 7(4):320-6. PubMed ID: 18928925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy.
    Reeder R; Carter DL; Howell K; Henkenberns P; Tallhamer M; Johnson T; Kercher J; Widner J; Kaske T; Paul D; Sedlacek S; Leonard CE
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):92-7. PubMed ID: 18786783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
    Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation.
    Shah C; Ghilezan M; Arthur D; Wilkinson JB; Keisch M; Chen P; Vicini FA
    Brachytherapy; 2012; 11(5):369-73. PubMed ID: 22192494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.
    Andolino DL; Forquer JA; Henderson MA; Barriger RB; Shapiro RH; Brabham JG; Johnstone PA; Cardenes HR; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):692-7. PubMed ID: 21288656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity.
    Cuttino LW; Todor D; Rosu M; Arthur DW
    Brachytherapy; 2009; 8(2):223-226. PubMed ID: 19211310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
    Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contura Multi-Lumen Balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial.
    Arthur DW; Vicini FA; Todor DA; Julian TB; Cuttino LW; Mukhopadhyay ND
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):264-9. PubMed ID: 23433798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.